Dec 5, 2006

Indian pharma industry booming

Over the past decade India has built itself to be a distinguished hub for R&D, manufacturing, and information sciences in the global healthcare economy. But what is next? What impact will India's growing role as a center for discovering and developing new drugs have on the world's pharmaceutical industry?
"Impact India: Pharmaceutical R&D Global Summit," taking place February 4-7, 2007 in New Delhi, India, is a new event organized by ALM's Strategic Research Institute designed to bring together pharma and biotech executives from around the world to gather strategic information and network amongst each other to facilitate new investment and foster new partnerships.

Speakers from the top multinational pharmaceutical and local India companies, including Pfizer, Eli Lilly & Co., Novartis, Bristol-Myers Squibb, Merck & Co., Ranbaxy, and Biocon, present their latest thoughts on the burgeoning Indian market and the challenges and opportunities that must be considered.

Buy Calls In Pharama :

Cipla
Ranbaxy
Wanbaury
Divi's labs
Aurobindo

No comments: